United States Contraceptive Devices Market Size and Share - Growth Analysis Report and Forecast Trends (2026-2035)

United States Contraceptive Devices Market Overview

Contraceptive devices play a critical role in family planning and reproductive health, offering effective, reversible, and long-term solutions for preventing unintended pregnancies. These devices range from intrauterine devices and implants to barriers and diaphragms, catering to diverse needs and preferences across populations. The United States contraceptive devices market is witnessing steady growth, driven by rising awareness of reproductive health, technological advancements, and increasing demand for safe and reliable birth control methods. The market is poised to reach USD 4.18 Billion by 2035, reflecting strong adoption across healthcare providers, pharmacies, and e-commerce platforms. Innovations and government initiatives continue to support market expansion and accessibility.

United States Contraceptive Devices Market Growth Driver

Rising Contraceptive Adoption to Propel the Market Demand

The increasing adoption of contraceptive methods is a factor driving the growth in the market. According to the Centers for Disease Control and Prevention (CDC), between 2022 and 2023, 54.3% of females aged 15-49 in the United States reported current use of contraception. This high prevalence indicates a growing awareness and acceptance of family planning measures, alongside supportive healthcare policies and educational initiatives. Such developments are expected to propel the demand for advanced and diverse contraceptive devices, contributing significantly to sustained market growth in the coming years.

United States Contraceptive Devices Market Trends

Some of the trends in the market include the increasing demand for smaller intrauterine devices (IUDs) and the growing availability of nonprescription oral contraceptives.

Growing Demand for Smaller IUDs is Likely to Boost the Market Value

The market is witnessing a notable trend toward the adoption of smaller intrauterine devices (IUDs) designed for women who have not given birth. Research from the Perelman School of Medicine at the University of Pennsylvania, published in NEJM Evidence in August 2025, highlights that mini copper IUDs available in Europe and Canada are associated with lower rates of removal due to bleeding and pelvic pain, while maintaining high contraceptive efficacy. As pharmaceutical companies develop and introduce similar smaller IUDs for the U.S. market, this trend is expected to enhance market growth by expanding options and improving user satisfaction.

Rising Accessibility of Nonprescription Oral Contraceptives to Elevate the United States Contraceptive Devices Market Expansion

The shift towards increased accessibility, driven by regulatory approvals for over-the-counter options, is a key trend shaping the market. For instance, in July 2023, the U.S. Food and Drug Administration approved Opill (norgestrel) as the first daily oral contraceptive available without a prescription, allowing consumers to purchase it at pharmacies, grocery stores, and online. This development reduces barriers to contraceptive access and supports safer, more effective family planning. Such innovations are expected to drive sustained market growth by expanding consumer choice and convenience in contraceptive solutions.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

United States Contraceptive Devices Market Share

Female Contraceptive Device Expected to Lead the Market Share by Product Type

The market is segmented by product type into male contraceptive devices and female contraceptive devices, with female contraceptive devices expected to lead the market, driven by increasing awareness of long-term birth control options and the growing preference for highly effective, low-maintenance solutions. For instance, intrauterine devices, representing a key subsegment under female solutions, have gained strong traction due to their extended protection period and reversible nature. In February 2025, the United States Food and Drug Administration approved Miudella®, a next-generation hormone-free copper intrauterine device by Sebela Women’s Health Inc., supporting wider adoption and reinforcing growth across this segment.

Leading Players in the United States Contraceptive Devices Market

Other key players in the market include Cooper Surgicals, Abbvie Inc., Church & Dwight Co., Inc., and Reckitt Benckiser Group PLC.

United States Contraceptive Devices Market Segmentation

Key Questions Answered in the United States Contraceptive Devices Market Report

• What was the United States contraceptive devices market value in 2025?
• What is the United States contraceptive devices market forecast outlook for 2026-2035?
• What are the major factors aiding the United States contraceptive devices market demand?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major United States contraceptive devices market trends?
• Which product type is expected to dominate the market segment?
• Which technology is projected to lead the market segment?
• Which distribution channel is anticipated to drive the market segment?
• Who are the key players involved in the United States contraceptive devices market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?